Chi Sheng Chemical Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 08, 2018 at 02:27 pm
Share
Chi Sheng Chemical Corp. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 243.504 million compared to TWD 274.213 million a year ago. Net income was TWD 16.062 million compared to TWD 24.047 million a year ago. Basic earnings per share was TWD 0.28 compared to TWD 0.42 a year ago. For the nine months, sales was TWD 725.618 million compared to TWD 785.055 million a year ago. Net income was TWD 35.926 million compared to TWD 65.416 million a year ago. Basic earnings per share was TWD 0.63 compared to TWD 1.15 a year ago. Diluted earnings per share was TWD 0.63 compared to TWD 1.14 a year ago.
Chi Sheng Pharma & Biotech Co., Ltd, formerly Chi Sheng Chemical Corporation is principally engaged in the manufacture and distribution of general medicines and medicinal injections. The Company provides injections, including hemodialysis concentrate, amino acid injection with electrolytes, vitamins, cephalosporin antibiotics, antihistamines and antipruritics, as well as ginkgo injections; oral preparations, including antibiotics, cold syrups and liquid antacid; external medicines, including contact lens fluid, normal saline for wash and povidone-iodine solution, and consumer goods, including functional health foods, skin care products and cosmetics. It also provides medical devices and equipment. The Company distributes its products in domestic markets and to overseas markets, including Mainland China and Southeast Asia.
CHI SHENG PHARMA & BIOTECH CO., LTD 
